Dexcom, Inc. vs. Abbott Diabetes Care Inc.

Explore the PTAB proceeding IPR2023-01409 filed by Dexcom, Inc. on 2023-10-11. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-01409

Filing Date

2023-10-11

Accorded Filing Date

2023-10-11

Institution Decision Date

2024-04-15

Last Modified Date

2025-01-07

Proceeding Type

IPR

Termination Date

2025-01-07

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Dexcom, Inc.

Represented By

Mason, Andrewet al

Patent Owner / Respondent

Abbott Diabetes Care Inc.

Represented By

McAndrews, Peteret al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 3700 - Mechanical Engineering & Manufacturing

Patent Information

1 Patent Involved

Respondent Application Number 17221154

Respondent Patent Number 11202591

External Links

Espacenet

Google Patents

Respondent Inventor Phillip Yee et al

Respondent Tech Center TC 3700 - Mechanical Engineering & Manufacturing

Address and Attorney/Agent Information

30 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name One LLP - ADC - Alana Fredericks

Customer Number 183890

Address 23 Corporate Plaza, Suite 150, Newport Beach, CA, 92660, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
33349	Thomas Rendos	651-756-6480
39046	Mimi Goller	847-935-7550
40499	Audrey Bartnicki	847-938-3440
41091	Jonathan Jaech	949-444-5941
45455	Jon Trachtenberg	978-577-3417
47004	Rachel Polster	847-937-0107
47822	Peter Nichols	818-493-2323
48056	Chien Yuan	914-524-2094
48306	James Rodgers	651-756-2000
48439	Irene Reininger	847-938-3797
50756	Mark Stirrat	949-502-2870
51586	Christopher Crawford	972-309-8006
52848	Irene Eckert	651-756-4443
54550	Diane Pang	949-502-2870
58927	Mark Engle	614-624-7080
59018	Urmi Chattopadhyay	415-291-6200
59677	Sandra Weida	614-624-6657
59986	Randy Shen	408-845-1439
68469	Jennifer Meline	901-344-1249
68987	Uyen Tang	714-961-4310
70119	Meng Xu	949-502-2870
71606	Carlos Espinoza	818-362-6822
72307	Hanna Yoon	650-866-8548
72633	Scott Krueger	612-337-7213
73330	Laura Hupp	612-766-6011
74086	Robin Plachy	224-668-5239
74574	Kara Wanstrath Perry	815-715-6628
75058	Glen Liu	949-432-9993
75181	Katherine Rahlin	612-492-7370
79555	Samareh Afrasiabi	949-502-2870

Proceeding Documents

149

TERMINATION Due to Settlement After Institution of Trial 35 U.S.C. § 317; 37 C.F.R. § 42.74 TERMINATE

2025-01-07 FILING PARTY: BOARD

Download

Joint Motion to Terminate Proceeding Under 35 USC 317(a) MOTION

2025-01-03 FILING PARTY: PETITIONER

Download

Joint Request to Treat Settlement Agreement as Business Confidential Information OTHER

2025-01-03 FILING PARTY: PETITIONER

Download

ORDER Setting Oral Argument 37 C.F.R. § 42.70 ORDER

2024-12-11 FILING PARTY: BOARD

Download

2056

Fletcher Deposition Exhibit 2056 Exhibit

2024-12-10 FILING PARTY: PATENT OWNER

Download

Dexcom, Inc. vs. Abbott Diabetes Care Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Dexcom, Inc.

Represented By

Patent Owner / Respondent

Abbott Diabetes Care Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

TERMINATION Due to Settlement After Institution of Trial 35 U.S.C. § 317; 37 C.F.R. § 42.74 TERMINATE

Joint Motion to Terminate Proceeding Under 35 USC 317(a) MOTION

Joint Request to Treat Settlement Agreement as Business Confidential Information OTHER

ORDER Setting Oral Argument 37 C.F.R. § 42.70 ORDER

Fletcher Deposition Exhibit 2056 Exhibit

Fletcher Deposition Exhibit 2063 Exhibit

Gary Fletcher 12-04-24 Deposition Transcript Exhibit

Patent Owner's Sur-Reply OTHER

Fletcher Deposition Exhibit 2062 Exhibit

Patent Owner's Request for Oral Argument OTHER

Petitioners Request for Oral Argument OTHER

Petitioner Dexcom, Inc.s Updated Mandatory Notices Pursuant to 37 C.F.R. 42.8(a)(3) NOTICE

Updated Power of Attorney of Petitioner Dexcom, Inc. NOTICE

Patent Owner's Notice of Deposition of Gary D. Fletcher, Ph.D. NOTICE

Patent Owner's Objections to Petitioner's Exhibits Submitted with Its Reply OTHER

Amendment and Response filed January 7, 2008, from Cote File History for U.S. Patent No. 7,731,691 Exhibit

Second Declaration of Gary D. Fletcher, Ph.D., dated October 25, 2024 Exhibit

U.S. Patent No. 11,298,056 (“’056 patent”) Exhibit

U.S. Publication No. 2004/0186365 (“Jin”) Exhibit

Petitioners Updated Exhibit List NOTICE

U.S. Publication No. 2005/0283114 (“Bresina”) Exhibit

Photographs showing patent marking on CLEO90 device Exhibit

Petitioners Reply to Patent Owners Response REPLYTOOPP

U.S. Patent No. 10,827,954 (“’954 patent”) Exhibit

“Answers to Frequently Asked Questions,” Freestyle Navigator System, from Wayback Machine, available at https://web.archive.org/web/20080917183534/http:/www.freestylenavigator.com/ab_nav/url/content/en_US/30.10.10:10/general_content/General_Content_0000004.htm (“Navigator FAQ”) Exhibit

Alvin H. Sacks, Ph.D., et al., Skin Blood Flow Changes and Tissue Deformations Produced by Cylindrical Indentors, Journal of Rehabilitation Research and Development Vol. 22 No. 3 (July 1985) (“Sacks”) Exhibit

Cleo90 Infusion Set Training Guide (from Wayback Machine) Exhibit

Abbott FreeStyle Navigator Continuous Glucose Monitoring System User’s Guide dated May 2008 Exhibit

DexCom STS Continuous Glucose Monitoring System User’s Guide (from Wayback Machine) (part 1) Exhibit

Declaration of Mung Conway, Paralegal, dated October 25, 2024 Exhibit

Neil T. Clancy, et al., A New Device for Assessing Changes in Skin Viscoelasticity Using Indentation and Optical Measurement, Skin Research and Technology (2010) (“Clancy”) Exhibit

Smiths Medical Cleo90 Infusion Set Product Literature, available at https://web.archive.org/web/20220816002119/https://www.smiths-medical.com/-/media/M/Smiths-medical_com/Files/Import-Files/Product-Literature/IN193873GB-092019_LR.pdf Exhibit

Conference Call Dated October 17, 2024 Exhibit

FDA 510(k) Premarket Notification page for CLEO90 Exhibit

Diabetes Patents, printed on October 21, 2024 from https://www.abbott.com/patents/diabetes-patents.html Exhibit

Food and Drug Administration approval of Cleo90 Infusion Set dated October 7, 2004 Exhibit

Code of Federal Regulations (2007) 29 C.F.R. § 1910.1030, Bloodborne pathogens Exhibit

DexCom STS Continuous Glucose Monitoring System User’s Guide (from Wayback Machine) (part 2) Exhibit

U.S. Patent No. 7,731,691 (“Cote Patent”) Exhibit

U.S. Patent No. 7,585,287 (“Bresina Patent”) Exhibit

Transcript of Deposition of Karl R. Leinsing, dated October 17, 2024 Exhibit

DexCom STS Continuous Glucose Monitoring System User’s Guide (from Wayback Machine) (part 3) Exhibit

Notice of Joint Stipulation to Modify Schedule NOTICE

Petitioners Notice of Deposition of Karl Leinsing NOTICE

2021 BIG Innovation Awards Exhibit

Hermanides Exhibit

Edison Awards Exhibit

2017 MDEA Award Exhibit

G7 Article Exhibit

van den Boom Exhibit

FreeStyle Libre FAQ Exhibit

Leinsing Declaration with Appendix B Chart Exhibit

FSL3 User's Guide Exhibit

G7 Review Exhibit

FSL3 Press Release Exhibit

2016 Edison Awards Exhibit

The Scientist 2019 Top 10 Innovations Exhibit

Patent Owner's Response RESPONSE

G6 Guide Exhibit

2023 Abbott Annual Report Exhibit

G7 Overview Webpage Exhibit

FSL3 Guide Exhibit

Galien Award Press Release Exhibit

FreeStyle Libre Review Exhibit

FSL 14-Day Guide Exhibit